BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
Lorenzo Bertani 1
Luca Antonioli
Marco Fornili
Vanessa D'Antongiovanni
Francesca Coppini
Ceccarelli Linda 2
Laura Benvenuti
Maria Gloria Mumolo
Laura Baglietto
Massimo Bellini
Matteo Fornai
Nicola de Bortoli
Francesco Costa
1 University of Pisa, Pisa, Italy
2 Pisa University Hospital, Pisa, Italy
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]